ABCALAMIVIR

Composition:
ABACAVIR & LAMIVUDINE 300/600 MG TABLETS
ABACAVIR & LAMIVUDINE 150/300 MG TABLETS

Indication:
Abacavir/Lamivudine is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults, adolescents and children weighing at least 25 kg
Before initiating treatment with abacavir, screening for carriage of the HLA-B*5701 allele should be performed in any HIV-infected patient, irrespective of racial origin. Abacavir should not be used in patients known to carry the HLA- B*5701 allele”